Literature DB >> 16550208

Ethical problems in pharmacogenetic studies of psychiatric disorders.

A Serretti1, P Artioli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16550208     DOI： 10.1038/sj.tpj.6500388

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  3 in total

1.  Personalized therapies in psychiatry: promises, pitfalls and perspectives.

Authors:  Katharina Domschke; Daniel J Müller; Alessandro Serretti
Journal:  J Neural Transm (Vienna)       Date:  2015-01       Impact factor: 3.575

2.  Taking part in a pharmacogenetic clinical trial: assessment of trial participants understanding of information disclosed during the informed consent process.

Authors:  Diana Rose; Jasna Russo; Til Wykes
Journal:  BMC Med Ethics       Date:  2013-09-11       Impact factor: 2.652

3.  The impact of advertising patient and public involvement on trial recruitment: embedded cluster randomised recruitment trial.

Authors:  Adwoa Hughes-Morley; Mark Hann; Claire Fraser; Oonagh Meade; Karina Lovell; Bridget Young; Chris Roberts; Lindsey Cree; Donna More; Neil O'Leary; Patrick Callaghan; Waquas Waheed; Peter Bower
Journal:  Trials       Date:  2016-12-08       Impact factor: 2.279
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.